Upcoming Investor Conferences for XOMA Royalty Corporation
XOMA Royalty Corporation (NASDAQ: XOMA), known for its role as a biotech royalty aggregator, has confirmed that members of its Executive Team will participate in several important investor conferences throughout March. These conferences are aimed at highlighting XOMA's contributions to biotechnology and its ongoing mission to improve human health through innovative partnerships.
Details of the Conferences
The first event on XOMA's schedule is the T.D. Cowen 45th Annual Health Care Conference. This event is set to take place from March 3 to March 5. The company's corporate presentation will occur on March 3 at 11:10 AM ET in Boston, Massachusetts. Management is expected to engage with investors and share insights into the company's strategic vision and potential growth areas.
Conference Features
During the Cowen conference, XOMA aims to articulate its commitments to advancing therapies that can significantly impact patient care. The discussion will center around how the company's unique approach allows it to acquire future economic interests in developmental biomedical innovations.
Second Conference Participation
Following the Cowen conference, XOMA will also be present at the Leerink 2025 Global Healthcare Conference from March 9 to March 12. A specific highlight will be a fireside chat scheduled for March 10 at 2:20 PM ET in Miami Beach, Florida. This setting will provide an intimate forum for investors to hear directly from XOMA's leadership about the company's future direction.
Investor Engagement Opportunities
These conferences present an excellent opportunity for investors to engage in one-on-one meetings with XOMA management. The discussions will focus on the company’s current projects and its vision for leveraging its extensive portfolio of royalty agreements.
Insights on XOMA Royalty's Business Model
XOMA Royalty Corporation’s business model centers on acquiring potential future revenues from pre-commercial and commercial therapeutic candidates. This strategy provides crucial funding to biotechnology companies without compromising their equity, allowing them to advance their drug development processes.
Additional Resources
For those looking to stay updated on XOMA’s activities and presentations, more information can be found in the investor relations section of the company’s official website. Here, investors can access live presentations and archived replays, ensuring they remain informed about the company’s trajectory.
Summary of Investor Contacts
For any inquiries regarding investor relations, you can reach:
Juliane Snowden
XOMA Royalty Corporation
+1 646-438-9754
juliane.snowden@xoma.com
Kathy Vincent
KV Consulting & Management
+1 310-403-8951
kathy@kathyvincent.com
Frequently Asked Questions
What is the focus of XOMA Royalty Corporation?
XOMA Royalty Corporation focuses on acquiring future economic revenues from biotechnology companies, supporting advancements in human health.
What events will XOMA participate in March?
XOMA will participate in the T.D. Cowen Annual Health Care Conference and the Leerink Global Healthcare Conference.
How do these conferences benefit investors?
The conferences allow investors to gain insights into XOMA's strategies and to meet with management to discuss company goals and projects.
Where can I access XOMA's investor presentations?
XOMA's investor presentations can be accessed on the company's official website in the investor relations section, with archives available for 90 days post-event.
Who should I contact for more information about XOMA Royalty?
You can contact Juliane Snowden for investor relations inquiries or Kathy Vincent for media-related questions.